Terms: = Skin cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Clinical Outcome
5 results:
1. A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantation.
Yang Z; Xie H; Wan J; Wang Y; Zhang L; Zhou K; Tang H; Zhao W; Wang H; Song P; Zheng S
EBioMedicine; 2023 Jun; 92():104594. PubMed ID: 37167784
[TBL] [Abstract] [Full Text] [Related]
2. Loss of Phd2 cooperates with BRAF
Liu S; Zhang G; Guo J; Chen X; Lei J; Ze K; Dong L; Dai X; Gao Y; Song D; Ecker BL; Yang R; Feltcher C; Peng K; Feng C; Chen H; Lee RX; Kerestes H; Niu J; Kumar S; Xu W; Zhang J; Wei Z; Martin JS; Liu X; Mills G; Lu Y; Guo W; Sun L; Zhang L; Weeraratna A; Herlyn M; Wei W; Lee FS; Xu X
Nat Commun; 2018 Dec; 9(1):5426. PubMed ID: 30575721
[TBL] [Abstract] [Full Text] [Related]
3. Combined mtor and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.
Rangwala R; Chang YC; Hu J; Algazy KM; Evans TL; Fecher LA; Schuchter LM; Torigian DA; Panosian JT; Troxel AB; Tan KS; Heitjan DF; DeMichele AM; Vaughn DJ; Redlinger M; Alavi A; Kaiser J; Pontiggia L; Davis LE; O'Dwyer PJ; Amaravadi RK
Autophagy; 2014 Aug; 10(8):1391-402. PubMed ID: 24991838
[TBL] [Abstract] [Full Text] [Related]
4. Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT.
Boers-Sonderen MJ; de Geus-Oei LF; Desar IM; van der Graaf WT; Oyen WJ; Ottevanger PB; van Herpen CM
Target Oncol; 2014 Dec; 9(4):339-47. PubMed ID: 24577626
[TBL] [Abstract] [Full Text] [Related]
5. AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma.
Namiki T; Tanemura A; Valencia JC; Coelho SG; Passeron T; Kawaguchi M; Vieira WD; Ishikawa M; Nishijima W; Izumo T; Kaneko Y; Katayama I; Yamaguchi Y; Yin L; Polley EC; Liu H; Kawakami Y; Eishi Y; Takahashi E; Yokozeki H; Hearing VJ
Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6597-602. PubMed ID: 21460252
[TBL] [Abstract] [Full Text] [Related]
